Evidence map›Paper›PMID 34543306›Full record

ArticlePloS one2021

Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge.

Ibrahim Jahun, Ishaq Said, Ibrahim El-Imam, Akipu Ehoche, Ibrahim Dalhatu, Aminu Yakubu, Stacie Greby, Megan Bronson, Kristin Brown, Moyosola Bamidele and 37 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Ibrahim JahunCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.ORCID 0000-0003-4190-1289
Ishaq SaidMaryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
Ibrahim El-ImamMaryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
Akipu EhocheMaryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
Ibrahim DalhatuCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Aminu YakubuCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Stacie GrebyCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Megan BronsonCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Kristin BrownCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Moyosola BamideleCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Andrew T BoydCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0001-6354-6818
Pamela BachanasCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0001-9408-9904
Emilio DirlikovCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0003-4631-2643
Chinedu AgbakwuruMaryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
Andrew AbutuCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Michelle Williams-SherlockCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Denis OnotuCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Solomon OdafeCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Daniel B WilliamsCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0003-1609-5748
Orji BasseyCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Obinna OgbanufeCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Chibuzor OnyenuobiCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Ayo AdeolaCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Chidozie MeribeCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Timothy EfuntoyeCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Omodele J FagbamigbeCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Ayodele FagbemiCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Uzoma EneCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Tingir NguhemenCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Ifunanya MgbakorCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Matthias AlagiCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Olugbenga AsaoluCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Ademola OladipoCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Joy AmafahCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
Charles NzeluFederal Ministry of Health, Abuja, Nigeria.
Patrick DakumInstitute of Human Virology (IHVN), Abuja, Federal Capital Territory, Nigeria.
Charles MensahInstitute of Human Virology (IHVN), Abuja, Federal Capital Territory, Nigeria.
Ahmad AliyuInstitute of Human Virology (IHVN), Abuja, Federal Capital Territory, Nigeria.ORCID 0000-0003-0203-4629
Prosper OkonkwoAIDS Prevention Initiative Nigeria (APIN), Abuja, Federal Capital Territory, Nigeria.
Bolanle OyeledunCenter for Integrated Health Program (CIHP), Abuja, Federal Capital Territory, Nigeria.
John OkoCatholic Caritas Foundation Nigeria (CCFN), Abuja, Federal Capital Territory, Nigeria.
Akudo IkpeazuFederal Ministry of Health, Abuja, Nigeria.
Aliyu GamboNational Agency for the Control of AIDS, Abuja, Federal Capital Territory, Nigeria.
Manhattan CharuratMaryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
Tedd EllerbrockCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Sani AliyuNational Agency for the Control of AIDS, Abuja, Federal Capital Territory, Nigeria.
Mahesh SwaminathanCenters for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.ORCID 0000-0001-5827-3245

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIneffective linkage to care (LTC) is a known challenge for community HIV testing. To overcome this challenge, a robust linkage to care strategy was adopted by the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS). The NAIIS linkage to care strategy was further adapted to improve Nigeria's programmatic efforts to achieve the 1st 90 as part of the Nigeria Antiretroviral Therapy (ART) Surge initiative, which also included targeted community testing. In this paper we provide an overview of the NAIIS LTC strategy and describe the impact of this strategy on both the NAIIS and the Surge initiatives.

methodsThe NAIIS collaborated with community-based organizations (CBOs) and deployed mobile health (mHealth) technology with real-time dashboards to manage and optimize community LTC for people living with HIV (PLHIV) diagnosed during the survey. In NAIIS, CBOs' role was to facilitate linkage of identified PLHIV in community to facility of their choice. For the ART Surge, we modified the NAIIS LTC strategy by empowering both CBOs and mobile community teams as responsible for not only active LTC but also for community testing, ART initiation, and retention in care.

resultsOf the 2,739 PLHIV 15 years and above identified in NAIIS, 1,975 (72.1%) were either unaware of their HIV-positive status (N = 1890) or were aware of their HIV-positive status but not receiving treatment (N = 85). Of these, 1,342 (67.9%) were linked to care, of which 952 (70.9%) were initiated on ART. Among 1,890 newly diagnosed PLHIV, 1,278 (67.6%) were linked to care, 33.7% self-linked and 66.3% were linked by CBOs. Among 85 known PLHIV not on treatment, 64 (75.3%) were linked; 32.8% self-linked and 67.2% were linked by a CBO. In the ART Surge, LTC and treatment initiation rates were 98% and 100%, respectively. Three-month retention for monthly treatment initiation cohorts improved from 76% to 90% over 6 months.

conclusionsActive LTC strategies by local CBOs and mobile community teams improved LTC and ART initiation in the ART Surge initiative. The use of mHealth technology resulted in timely and accurate documentation of results in NAIIS. By deploying mHealth in addition to active LTC, CBOs and mobile community teams could effectively scale up ART with real-time documentation of client-level outcomes.

Indexed as

TelemedicineAdolescentAdultAnti-Retroviral AgentsCross-Sectional StudiesDelivery of Health CareFemaleHIV InfectionsHumansMaleNigeriaSelf ReportSurveys and QuestionnairesYoung AdultAnti-Retroviral Agents

Identifiers

PMID34543306
PMCPMC8451986

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.